NL8004126A - De nieuwe pyridinonderivaten, werkwijze ter bereiding hiervan en farmaceutische preparaten die de pyridinondervivaten bevatten. - Google Patents

De nieuwe pyridinonderivaten, werkwijze ter bereiding hiervan en farmaceutische preparaten die de pyridinondervivaten bevatten. Download PDF

Info

Publication number
NL8004126A
NL8004126A NL8004126A NL8004126A NL8004126A NL 8004126 A NL8004126 A NL 8004126A NL 8004126 A NL8004126 A NL 8004126A NL 8004126 A NL8004126 A NL 8004126A NL 8004126 A NL8004126 A NL 8004126A
Authority
NL
Netherlands
Prior art keywords
pyridinone
pyridinyl
acid
hydroxymethyl
hydroxy
Prior art date
Application number
NL8004126A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NL8004126A publication Critical patent/NL8004126A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8004126A 1979-09-10 1980-07-17 De nieuwe pyridinonderivaten, werkwijze ter bereiding hiervan en farmaceutische preparaten die de pyridinondervivaten bevatten. NL8004126A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7388579 1979-09-10
US06/073,885 US4225601A (en) 1979-09-10 1979-09-10 3-Hydroxy or hydroxymethyl-5-(4-pyridinyl)2(1H)-pyridinones, useful as cardiotonic agents and their preparation

Publications (1)

Publication Number Publication Date
NL8004126A true NL8004126A (nl) 1981-03-12

Family

ID=22116385

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8004126A NL8004126A (nl) 1979-09-10 1980-07-17 De nieuwe pyridinonderivaten, werkwijze ter bereiding hiervan en farmaceutische preparaten die de pyridinondervivaten bevatten.

Country Status (21)

Country Link
US (1) US4225601A (xx)
JP (1) JPS5668670A (xx)
KR (1) KR830003470A (xx)
AR (1) AR223716A1 (xx)
AU (1) AU6003080A (xx)
BE (1) BE884329A (xx)
DE (1) DE3027901A1 (xx)
DK (1) DK314180A (xx)
ES (1) ES493583A0 (xx)
FI (1) FI802298A (xx)
FR (1) FR2465722A1 (xx)
GB (1) GB2058751A (xx)
IL (1) IL60360A0 (xx)
IT (1) IT1132192B (xx)
LU (1) LU82650A1 (xx)
NL (1) NL8004126A (xx)
NO (1) NO802138L (xx)
NZ (1) NZ194106A (xx)
PT (1) PT71427A (xx)
SE (1) SE8004934L (xx)
ZA (1) ZA803679B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361569A (en) * 1981-08-26 1982-11-30 Sterling Drug Inc. 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
US4463008A (en) * 1982-11-10 1984-07-31 Sterling Drug Inc. 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof
US6068581A (en) * 1998-04-29 2000-05-30 Timm Medical Technologies, Inc. Method and apparatus for testing and exercising pelvic muscles
EP2542077A4 (en) * 2010-03-04 2013-08-21 Merck Sharp & Dohme CATECHOL O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN THE TREATMENT OF PSYCHOTIC DISORDERS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
BE884329A (fr) 1981-01-16
FR2465722A1 (fr) 1981-03-27
IT1132192B (it) 1986-06-25
DK314180A (da) 1981-03-11
US4225601A (en) 1980-09-30
GB2058751A (en) 1981-04-15
PT71427A (en) 1980-07-01
ES8106514A1 (es) 1981-07-01
AR223716A1 (es) 1981-09-15
IL60360A0 (en) 1980-09-16
LU82650A1 (fr) 1981-03-24
NZ194106A (en) 1982-03-30
ZA803679B (en) 1981-06-24
SE8004934L (sv) 1981-03-11
NO802138L (no) 1981-03-11
FI802298A (fi) 1981-03-11
ES493583A0 (es) 1981-07-01
IT8023422A0 (it) 1980-07-14
KR830003470A (ko) 1983-06-20
AU6003080A (en) 1981-03-19
JPS5668670A (en) 1981-06-09
DE3027901A1 (de) 1981-03-26

Similar Documents

Publication Publication Date Title
FI66849B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2(h)-pyridinonderivat
CA1314044C (en) Imidazopyridine derivatives
KR880001623B1 (ko) 치환된 4, 5-디하이드로-6-(치환) 페닐-3(2h)-피리다지논류 및 6-(치환)페닐-3(2h)-피리다지논류
US4312875A (en) 5-(Pyridinyl)-6-(lower-alkyl)-2(1H)-pyridinones, 1,2-dihydro-2-oxo-5-(pyridinyl)-6-(lower-alkyl)nicotinic acids and lower-alkyl esters thereof, and cardiotonic use thereof
US4673675A (en) 1-(2-pyridyl) 4-cycloalkylmethyl piperazines having cardiotropic activity
LU82728A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones,leur preparation et leur utilisation therapeutique
NL8004126A (nl) De nieuwe pyridinonderivaten, werkwijze ter bereiding hiervan en farmaceutische preparaten die de pyridinondervivaten bevatten.
SU1299505A3 (ru) Способ получени 5-ацил-2( @ )-пиридинонов
FI76336B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrido/2,3-d/pyrimidin-5-oner.
JPS61210086A (ja) 強心薬として有用な1、6−ナフチリジン−2(ih)−オン類およびその製造方法
US4743608A (en) Pyridone-pyridyl-imidazolyl and triazolyl compounds and their use as cardiotonic agents
US4375467A (en) 5-(Pyridinyl)-1H-pyrazolo[3,4-b] pyridines and their cardiotonic use
NL8006511A (nl) Nieuwe bipyridineverbinding, alsmede farmaceutisch preparaat dat deze verbinding bevat.
US4297362A (en) 4-(3,4-Diaminophenyl)pyridine or salts, and use thereof as cardiotonic
NL8006824A (nl) Nieuwe pyridinonderivaten, alsmede farmaceutische preparaten.
JPS63501218A (ja) ピリジル−ピリダジノン化合物及びピリジル−ピラゾリノン化合物並びにそれらの充血性心不全治療上の用途
JPS59101466A (ja) 強心薬として有用なピリジン誘導体およびその製法
US4391811A (en) 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use
US4473571A (en) 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use
FR2496659A1 (fr) Derives de 1,2 dihydro-5(pyridinyl)nicotinamide, leur preparation et leur utilisation comme agents cardiotoniques et intermediaires
US4361569A (en) 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof
US4362735A (en) 3-[(3-Oxo-1-butenyl)amino]-5-(pyridinyl)-2(1H)-pyridinones and their cardiotonic use
KR870000960B1 (ko) 4-r'-5-q-1,6-나프티리딘-2(1h)-온류의 제법
US4503228A (en) 2-(Pyridinyl)-4,5,6-pyrimidinetriamines
LU82997A1 (fr) 6-(pyridinyl)-pyridazines,leur preparation et leur utilisation therapeutique

Legal Events

Date Code Title Description
BV The patent application has lapsed